Frontiers in Oncology | Hematologic Malignancies

Original Research

Published on 07 Jun 2022

Reduced Dose Intensity of Daunorubicin During Remission Induction for Low-Risk Patients With Acute Lymphoblastic Leukemia: A Retrospective Cohort Study of the Chinese Children’s Cancer Group

in Hematologic Malignancies

Yong Zhuang
Kefei Wu
Xiaofan Zhu
Jiaoyang Cai
Shaoyan Hu
Ju Gao
Hua Jiang
Xiaowen Zhai
Xin Tian
Yongjun Fang

Frontiers in Oncology

doi 10.3389/fonc.2022.911567

13,119 views
3 citations

Case Report

Published on 07 Jun 2022

A Novel IL3-ETV6 Fusion in Chronic Eosinophilic Leukemia Not Otherwise Specified With t(5; 12) (q31; p13): A Case Report and Literature Review

in Hematologic Malignancies

Cenzhu Zhao
Man Wang
Yuchen Zhan
Yang Xu
Suning Chen
Qinrong Wang
Jingnan An
Tianhui Liu

Frontiers in Oncology

doi 10.3389/fonc.2022.887945

3,476 views
8 citations

Review

Published on 07 Jun 2022

Pathogenesis and Treatment of T-Large Granular Lymphocytic Leukemia (T-LGLL) in the Setting of Rheumatic Disease

in Hematologic Malignancies

Nina Couette
Wael Jarjour
Jonathan E. Brammer
Alexa Simon Meara

Frontiers in Oncology

doi 10.3389/fonc.2022.854499

8,807 views
5 citations

Original Research

Published on 06 Jun 2022

The Clinical Characteristics and Prognosis of AYA and Older Adult ETP-ALL/LBL: A Real-World Multicenter Study in China

in Hematologic Malignancies

Jinyan Xiao
Zihong Cai
Hao Wang
Xuekai Li
Biqi Zhou
Yujie Liu
Ying Wang
Peipei Xu
Li Wang
Depei Wu

Frontiers in Oncology

doi 10.3389/fonc.2022.846573

5,826 views
8 citations

Case Report

Published on 06 Jun 2022

Case Report: Sequential Development of Three Mature Lymphoid Neoplasms in a Single Patient: Clonal Relationship and Molecular Insights

in Hematologic Malignancies

Chiara Salvetti
Candida Vitale
Valentina Griggio
Daniela Drandi
Rebecca Jones
Lisa Bonello
Riccardo Bomben
Alberto Bragoni
Davide Bagnara
Franco Fais

Frontiers in Oncology

doi 10.3389/fonc.2022.917115

2,941 views
8 citations

Original Research

Published on 06 Jun 2022

Plasma Metabolites Forecast Occurrence and Prognosis for Patients With Diffuse Large B-Cell Lymphoma

in Hematologic Malignancies

Fei Fei
Meihong Zheng
Zhenzhen Xu
Runbin Sun
Xin Chen
Bei Cao
Juan Li

Frontiers in Oncology

doi 10.3389/fonc.2022.894891

4,364 views
13 citations

Original Research

Published on 02 Jun 2022

IGH Translocations in Chinese Patients With Chronic Lymphocytic Leukemia: Clinicopathologic Characteristics and Genetic Profile

in Hematologic Malignancies

Qinlu Li
Shugang Xing
Heng Zhang
Xiao Mao
Min Xiao
Ying Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.858523

2,957 views
4 citations

Original Research

Published on 02 Jun 2022

Underexpression of LINC00173 in TCF3/PBX1-Positive Cases Is Associated With Poor Prognosis in Children With B-Cell Precursor Acute Lymphoblastic Leukemia

in Hematologic Malignancies

Didier Ismael May-Hau
Diego Alberto Bárcenas-López
Juan Carlos Núñez-Enríquez
Vilma Carolina Bekker-Méndez
Fredy Omar Beltrán-Anaya
Elva Jiménez-Hernández
Mónica Patricia Ortíz-Maganda
Francisco Xavier Guerra-Castillo
Aurora Medina-Sanson
Janet Flores-Lujano

Frontiers in Oncology

doi 10.3389/fonc.2022.887766

5,367 views
4 citations

Systematic Review

Published on 01 Jun 2022

Meta-Analysis of Risk Factors and Incidence of Interstitial Pneumonia With CHOP-Like Regimens for Non-Hodgkin Lymphoma

in Hematologic Malignancies

Jing Yang
Limin Chai
Junting Jia
Liping Su
Zhiying Hao

Frontiers in Oncology

doi 10.3389/fonc.2022.880144

3,296 views
3 citations

Original Research

Published on 30 May 2022

UNC13B Promote Arsenic Trioxide Resistance in Chronic Lymphoid Leukemia Through Mitochondria Quality Control

in Hematologic Malignancies

Xiao-Bo Wang
Li-Hua Yuan
Le-Ping Yan
Yong-Bin Ye
Bo Lu
Xiaojun Xu

Frontiers in Oncology

doi 10.3389/fonc.2022.920999

3,139 views
6 citations

Original Research

Published on 27 May 2022

Modified Stage Grouping of Diffuse Large B-Cell Lymphoma Involving the Same Side of the Diaphragm in the Rituximab Era

in Hematologic Malignancies

Hyehyun Jeong
Hyungwoo Cho
Jung Yong Hong
Dae Ho Lee
Shin Kim
Kyoungmin Lee
Eun Hee Kang
Jung Sun Park
Jin Sook Ryu
Jooryung Huh

Frontiers in Oncology

doi 10.3389/fonc.2022.888925

3,033 views
1 citation

Review

Published on 26 May 2022

The Role of Exosomes in the Progression and Therapeutic Resistance of Hematological Malignancies

in Hematologic Malignancies

Haobing Wang
Yong You
Xiaojian Zhu

Frontiers in Oncology

doi 10.3389/fonc.2022.887518

4,399 views
16 citations

Case Report

Published on 25 May 2022

Case Report: Extramedullary Acute Promyelocytic Leukemia: An Unusual Case and Mini-Review of the Literature

in Hematologic Malignancies

Dennis Christoph Harrer
Florian Lüke
Ingo Einspieler
Karin Menhart
Dirk Hellwig
Kirsten Utpatel
Wolfgang Herr
Albrecht Reichle
Daniel Heudobler

Frontiers in Oncology

doi 10.3389/fonc.2022.886436

4,692 views
9 citations

Mini Review

Published on 25 May 2022

Fibrillary Glomerulonephritis and Monoclonal Gammopathy: Potential Diagnostic Challenges

in Hematologic Malignancies

Yi Da
Giap Hean Goh
Titus Lau
Wee Joo Chng
Cinnie Yentia Soekojo

Frontiers in Oncology

doi 10.3389/fonc.2022.880923

6,068 views
8 citations

Original Research

Published on 24 May 2022

Childhood Acute B-Lineage Lymphoblastic Leukemia With CDKN2A/B Deletion Is a Distinct Entity With Adverse Genetic Features and Poor Clinical Outcomes

in Hematologic Malignancies

Jing Feng
Ye Guo
Wenyu Yang
Yao Zou
Li Zhang
Yumei Chen
Yingchi Zhang
Xiaofan Zhu
Xiaojuan Chen

Frontiers in Oncology

doi 10.3389/fonc.2022.878098

6,391 views
17 citations

Original Research

Published on 23 May 2022

The Prognostic Utility of 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography-Based Analyses of Metabolic Response Rates in Newly Diagnosed Diffuse Large B Cell Lymphoma Patients

in Hematologic Malignancies

Cong Li
Haifeng Yu
Xi Chen
Shuiyun Han
Shuailing Peng
Tao Lei
Haiyan Yang

Frontiers in Oncology

doi 10.3389/fonc.2022.772773

2,604 views
5 citations

Review

Published on 23 May 2022

Galectin Family Members: Emerging Novel Targets for Lymphoma Therapy?

in Hematologic Malignancies

Yuanwei Shi
Danting Tang
Xiaoqi Li
Xiaoli Xie
Yufu Ye
Lijuan Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.889034

6,004 views
13 citations

Review

Published on 19 May 2022

Cellular and Molecular Biomarkers Predictive of Response to Immunotherapy in Acute Myeloid Leukemia

in Hematologic Malignancies

Kyle Wiatrowski
Tae Hee Kim
Amanda Przespolewski

Frontiers in Oncology

doi 10.3389/fonc.2022.826768

4,324 views
6 citations

Original Research

Published on 18 May 2022

Prognostic Significance of the Stage at Which an MRD-Negative Status Is Achieved for Patients With Multiple Myeloma Who Received ASCT

in Hematologic Malignancies

Qian Sun
Xiaozhe Li
Jingli Gu
Beihui Huang
Junru Liu
Meilan Chen
Juan Li

Frontiers in Oncology

doi 10.3389/fonc.2022.776920

4,109 views
5 citations

Brief Research Report

Published on 18 May 2022

The Utility of Euroflow MRD Assessment in Real-World Multiple Myeloma Practice

in Hematologic Malignancies

Rose Turner
Anna Kalff
Krystal Bergin
Malgorzata Gorniak
Shaun Fleming
Andrew Spencer

Frontiers in Oncology

doi 10.3389/fonc.2022.820605

5,983 views
9 citations

Clinical Trial

Published on 16 May 2022

Clinical Outcomes of BCMA CAR-T Cells in a Multiple Myeloma Patient With Central Nervous System Invasion

in Hematologic Malignancies

Ting Wang
Ting He
Lie Ma
Yazi Yang
Ru Feng
Yanping Ding
Yueming Shan
Bing Bu
Feifei Qi
Fei Wu

Frontiers in Oncology

doi 10.3389/fonc.2022.854448

7,774 views
13 citations

Review

Published on 13 May 2022

Intersection Between Large Granular Lymphocyte Leukemia and Rheumatoid Arthritis

in Hematologic Malignancies

Katharine B. Moosic
Kusuma Ananth
Felipe Andrade
David J. Feith
Erika Darrah
Thomas P. Loughran

Frontiers in Oncology

doi 10.3389/fonc.2022.869205

14,529 views
25 citations

Case Report

Published on 13 May 2022

Case Report: Intravascular Large B-Cell Lymphoma: A Clinicopathologic Study of Four Cases With Review of Additional 331 Cases in the Literature

in Hematologic Malignancies

Yingying Han
Qingjiao Li
Dan Wang
Lushan Peng
Tao Huang
Chunlin Ou
Keda Yang
Junpu Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.883141

6,921 views
20 citations

Original Research

Published on 13 May 2022

NIPA (Nuclear Interaction Partner of ALK) Is Crucial for Effective NPM-ALK Mediated Lymphomagenesis

in Hematologic Malignancies

Stefanie Kreutmair
Lena Johanna Lippert
Cathrin Klingeberg
Corinna Albers-Leischner
Salome Yacob
Valeria Shlyakhto
Tony Mueller
Alina Mueller-Rudorf
Chuanjiang Yu
Sivahari Prasad Gorantla

Frontiers in Oncology

doi 10.3389/fonc.2022.875117

3,181 views
2 citations

2,059 articles

articles

Reduced Dose Intensity of Daunorubicin During Remission Induction for Low-Risk Patients With Acute Lymphoblastic Leukemia: A Retrospective Cohort Study of the Chinese Children’s Cancer Group

A Novel IL3-ETV6 Fusion in Chronic Eosinophilic Leukemia Not Otherwise Specified With t(5; 12) (q31; p13): A Case Report and Literature Review

Pathogenesis and Treatment of T-Large Granular Lymphocytic Leukemia (T-LGLL) in the Setting of Rheumatic Disease

The Clinical Characteristics and Prognosis of AYA and Older Adult ETP-ALL/LBL: A Real-World Multicenter Study in China

Case Report: Sequential Development of Three Mature Lymphoid Neoplasms in a Single Patient: Clonal Relationship and Molecular Insights

Plasma Metabolites Forecast Occurrence and Prognosis for Patients With Diffuse Large B-Cell Lymphoma

IGH Translocations in Chinese Patients With Chronic Lymphocytic Leukemia: Clinicopathologic Characteristics and Genetic Profile

Underexpression of LINC00173 in TCF3/PBX1-Positive Cases Is Associated With Poor Prognosis in Children With B-Cell Precursor Acute Lymphoblastic Leukemia

Meta-Analysis of Risk Factors and Incidence of Interstitial Pneumonia With CHOP-Like Regimens for Non-Hodgkin Lymphoma

UNC13B Promote Arsenic Trioxide Resistance in Chronic Lymphoid Leukemia Through Mitochondria Quality Control

Modified Stage Grouping of Diffuse Large B-Cell Lymphoma Involving the Same Side of the Diaphragm in the Rituximab Era

The Role of Exosomes in the Progression and Therapeutic Resistance of Hematological Malignancies

Case Report: Extramedullary Acute Promyelocytic Leukemia: An Unusual Case and Mini-Review of the Literature

Fibrillary Glomerulonephritis and Monoclonal Gammopathy: Potential Diagnostic Challenges

Childhood Acute B-Lineage Lymphoblastic Leukemia With CDKN2A/B Deletion Is a Distinct Entity With Adverse Genetic Features and Poor Clinical Outcomes

The Prognostic Utility of 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography-Based Analyses of Metabolic Response Rates in Newly Diagnosed Diffuse Large B Cell Lymphoma Patients

Galectin Family Members: Emerging Novel Targets for Lymphoma Therapy?

Cellular and Molecular Biomarkers Predictive of Response to Immunotherapy in Acute Myeloid Leukemia

Prognostic Significance of the Stage at Which an MRD-Negative Status Is Achieved for Patients With Multiple Myeloma Who Received ASCT

The Utility of Euroflow MRD Assessment in Real-World Multiple Myeloma Practice

Clinical Outcomes of BCMA CAR-T Cells in a Multiple Myeloma Patient With Central Nervous System Invasion

Intersection Between Large Granular Lymphocyte Leukemia and Rheumatoid Arthritis

Case Report: Intravascular Large B-Cell Lymphoma: A Clinicopathologic Study of Four Cases With Review of Additional 331 Cases in the Literature

NIPA (Nuclear Interaction Partner of ALK) Is Crucial for Effective NPM-ALK Mediated Lymphomagenesis